Skip to main content
. 2014 May 19;13:111. doi: 10.1186/1476-4598-13-111

Table 1.

Clinical characteristics of NPC patients according to high and low CIP2A expression

Characteristics
No. of patients
Expression of CIP2A
P value
    Low, n (%) High, n (%)  
Age
 
 
 
 
≤45
130
48 (50)
82 (45)
0.39
>45
150
48 (50)
102 (55)
 
Sex
 
 
 
 
Male
208
72 (75)
136 (74)
0.84
Female
72
24 (25)
48 (26)
 
WHO type
 
 
 
 
I + II
10
2 (2)
8 (6)
0.50
III
270
94 (98)
176 (94)
 
VCA-IgA
 
 
 
 
< 1:80
41
16 (17)
25 (14)
0.49
≥ 1:80
239
80 (83)
159 (86)
 
EA-IgA
 
 
 
 
< 1:10
68
24 (25)
44 (24)
0.84
≥ 1:10
212
72 (75)
140 (76)
 
T Stage
 
 
 
 
T1-T2
137
55 (57)
82 (45)
0.04
T3-T4
143
41 (43)
102 (55)
 
N Stage
 
 
 
 
N0-N1
173
61 (64)
112 (61)
0.66
N2-N3
107
35 (36)
72 (39)
 
TNM Stage
 
 
 
 
I-II
86
40 (42)
46 (25)
<0.01
III-IV
194
56 (58)
138 (75)
 
Locoregional failure
 
 
 
 
Yes
38
11 (11)
27 (15)
0.46
No
242
85 (89)
157 (85)
 
Distant metastasis
 
 
 
 
Yes
63
11 (11)
52 (28)
<0.01
No
217
85 (89)
132 (72)
 
Death
 
 
 
 
Yes
67
14 (15)
53 (29)
0.01
No 213 82 (85) 131 (71)